Introduction to Refractory Neurogenic

What is/are Refractory Neurogenic?

Refractory Neurogenic - CONCLUSION In our series, 38% had clinical success with intradetrusor Botox injections for refractory neurogenic bladder. ^[1] Conclusions The results confirmed that augmentation ileocystoplasty had excellent long-term outcomes in the definitive therapy of refractory neurogenic detrusor overactivity in patients with SCI. ^[2] We successfully performed intravesical onabotulinumtoxinA therapy for refractory neurogenic overactive bladder due to human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis. ^[3] BACKGROUND A randomized, double-blind, non-inferiority clinical study was performed on the efficacy and tolerability of IncobotulinumtoxinA vs OnabotulinumtoxinA intradetrusor injections in patients with refractory neurogenic detrusor overactivity incontinence performing intermittent catheterization. ^[4] The objective was to evaluate the use of botulinum toxin A (BTX-A) injection in children with medically refractory neurogenic bladder. ^[5] Diversion procedures are used to reroute urine after cystectomy and in patients with refractory neurogenic or outlet obstruction of the urinary bladder. ^[6] This is a case of an improperly restrained child presenting with spinal cord injury and refractory neurogenic shock after MVC. ^[7] INTRODUCTION AND OBJECTIVES: Robot-assisted laparoscopic augmentation ileocystoplasty with Mitrofanoff appendicovesicostomy (RALIMA) may protect the upper urinary tract and reestablish continence in patients with refractory neurogenic bladder. ^[8] DESIGN, SETTING, AND PARTICIPANTS A pilot study including nine patients with refractory neurogenic LUTD investigated prospectively at a university neuro-urology department. ^[9]

refractory neurogenic bladder

CONCLUSION In our series, 38% had clinical success with intradetrusor Botox injections for refractory neurogenic bladder. ^[1] The objective was to evaluate the use of botulinum toxin A (BTX-A) injection in children with medically refractory neurogenic bladder. ^[2] INTRODUCTION AND OBJECTIVES: Robot-assisted laparoscopic augmentation ileocystoplasty with Mitrofanoff appendicovesicostomy (RALIMA) may protect the upper urinary tract and reestablish continence in patients with refractory neurogenic bladder. ^[3]

refractory neurogenic detrusor

Conclusions The results confirmed that augmentation ileocystoplasty had excellent long-term outcomes in the definitive therapy of refractory neurogenic detrusor overactivity in patients with SCI. ^[1] BACKGROUND A randomized, double-blind, non-inferiority clinical study was performed on the efficacy and tolerability of IncobotulinumtoxinA vs OnabotulinumtoxinA intradetrusor injections in patients with refractory neurogenic detrusor overactivity incontinence performing intermittent catheterization. ^[2]